XML 27 R14.htm IDEA: XBRL DOCUMENT

Warrant Liability

3 Months Ended

Mar. 31, 2012

Note 8. Warrant Liability

We use various option pricing models, such as the Black-Scholes option pricing model and the Monte Carlo simulation model, to estimate fair value of warrants issued. In using these models, we make certain assumptions about risk-free interest rates, dividend yields, volatility, expected term of the warrants and other assumptions. Risk-free interest rates are derived from the yield on U.S. Treasury debt securities. Dividend yields are based on our historical dividend payments, which have been zero to date. Volatility is estimated from the historical volatility of our common stock as traded on NASDAQ. The expected term of the warrants is based on the time to expiration of the warrants from the date of measurement. Share numbers and exercise prices have been adjusted for the 1-for-10 reverse stock split.

In November 2008, we sold 1,379,310 units to institutional investors at a price of $14.50 per unit, for gross proceeds of $20,000,000. The units, each of which consisted of one share of common stock and a warrant to purchase 0.75 shares of common stock at an exercise price of $23.00 per share, were offered as a registered direct offering under a shelf registration statement previously filed with, and declared effective by, the SEC. We received total proceeds, net of offering expenses and placement agency fees, of approximately $18,637,000. We recorded the fair value of the warrants to purchase 1,034,483 shares of our common stock as a liability. The fair value of the warrant liability will be revalued at the end of each reporting period, with the change in fair value of the warrant liability recorded as a gain or loss in our condensed consolidated statements of operations. The fair value of the warrants will continue to be classified as a liability until such time as the warrants are exercised, expire or an amendment of the warrant agreement renders these warrants to be no longer classified as a liability.

The assumptions used for the Black-Scholes option pricing model are as follows:


	To Calculate Fair Value of Warrant Liability at
	March 31, 2012			December 31, 2011
Expected life (years)		2.1			2.4
Risk-free interest rate		0.4	%		0.3	%
Expected volatility		74.2	%		74.1	%
Expected dividend yield		0	%		0	%


	At March 31, 2012		At December 31, 2011		Change in Fair Value of Warrant Liability
Fair value of warrant liability	$	3,807	$	2,224	$	1,583

In November 2009, we sold 1,000,000 units to institutional investors at a price of $12.50 per unit, for gross proceeds of $12,500,000. The units, each of which consisted of one share of common stock and a warrant to purchase 0.40 shares of common stock at an exercise price of $15.00 per share, were offered as a registered direct offering under a shelf registration statement previously filed with, and declared effective by, the SEC. We received total proceeds, net of offering expenses and placement agency fees, of approximately $11,985,000. We recorded the fair value of the warrants to purchase 400,000 shares of our common stock as a liability. The fair value of the warrant liability will be revalued at the end of each reporting period, with the change in fair value of the warrant liability recorded as a gain or loss in our condensed consolidated statements of operations. The fair value of the warrants will continue to be classified as a liability until such time as the warrants are exercised, expire or an amendment of the warrant agreement renders these warrants to be no longer classified as a liability.

The assumptions used for the Black-Scholes option pricing model are as follows:


	To Calculate Fair Value of Warrant Liability at
	March 31, 2012			December 31, 2011
Expected life (years)		3.1			3.3
Risk-free interest rate		0.5	%		0.5	%
Expected volatility		74.1	%		90.8	%
Expected dividend yield		0	%		0	%


	At March 31, 2012		At December 31, 2011		Change in Fair Value of Warrant Liability
Fair value of warrant liability	$	15,376	$	28,971	$	(13,595	)

In December 2011, we raised gross proceeds of $10,000,000 through a public offering of 8,000,000 units and 8,000,000 Series B Warrants. The combination of units and Series B Warrants were sold at a public offering price of $1.25 per unit. Each Series B Warrant gives the holder the right to purchase one unit at an exercise price of $1.25 per unit and is exercisable until May 2, 2012, the 90th trading day after the date of issuance. Each unit consists of one share of our common stock and one Series A Warrant. Each Series A Warrant gives the holder the right to purchase one share of our common stock at an initial exercise price of $1.40 per share. The Series A Warrants are immediately exercisable upon issuance and will expire on the fifth anniversary of the closing date of the initial financing transaction in December 2011. The shares were offered under our effective shelf registration statement previously filed with the SEC.

In the first quarter of 2012, an aggregate of 900,000 Series B Warrants were exercised. For the exercise of these warrants, we issued 900,000 shares of our common stock and 900,000 Series A Warrants with an exercise price of $1.40 per share and received gross proceeds of approximately $813,000 in the first quarter of 2012 and $313,000 in April 2012.

The assumptions used for the Monte Carlo simulation model to value the Series A and Series B Warrants at March 31, 2012 are as follows:


Risk-free interest rate per year	0.9	%
Expected volatility per year	84.2	%
Expected dividend yield	0	%
Expected life for Series A = 4.7 years and for Series B = 0.09 years

The use of the Monte Carlo simulation model requires the input of additional subjective assumptions including the progress of our R&D programs and its affect on potential future financings.

The following table is a summary of the changes in fair value of warrant liability for the Series A and Series B Warrants for the three-month period ended March 31, 2012:


	Series A				Series B
	Number of Warrants		Fair value $		Number of Warrants			Fair value $
Balance at December 31, 2011		8,000,000		3,790,160		8,000,000			2,220,960
Add Issued		900,000		607,818		0			0
Less exercised		0		0		(900,000	)		(568,003	)
Changes in fair value at period end		0		1,837,006		0			3,116,183

Balance at March 31, 2012		8,900,000		6,234,984		7,100,000			4,769,140

The following table is a summary of our outstanding warrants and fair value of our warrant liability as of March 31, 2012:


Warrants	Number Outstanding		Exercise Price $		Fair value $
Warrants issued in 2008		1,034,483		23.00		3,807
Warrants issued in 2009		400,000		15.00		15,376
Series A		8,900,000		1.40		6,234,984
Series B		7,100,000		1.25		4,769,140

Total		17,434,483				11,023,307

The fair value of the warrant liability will be revalued at the end of each reporting period, with the change in fair value of the warrant liability recorded as a gain or loss in our condensed consolidated statements of operations. The fair value of the warrants will continue to be classified as a liability until such time as the warrants are exercised, expire or an amendment of the warrant agreement renders these warrants to be no longer classified as a liability.